United Therapeutics Corp (NASDAQ:UTHR)

116.55
Delayed Data
As of 3:59pm ET
 +5.08 / +4.56%
Today’s Change
75.58
Today|||52-Week Range
127.79
+32.32%
Year-to-Date
United Therapeutics Corp (UTHR) Q2 2020 Earnings Call Transcript
Jul 29 / MotleyFool.com - Paid Partner Content
United Therapeutics Q2 2020 Earnings Preview
Jul 28 / Seeking Alpha - Paid Partner Content
United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q2 2020 Results - Earnings Call Transcript
Jul 29 / Seeking Alpha - Paid Partner Content
Notable earnings before Wednesday's open
Jul 28 / Seeking Alpha - Paid Partner Content
United Therapeutics EPS beats by $0.41, beats on revenue
Jul 29 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close111.47
Today’s open113.09
Day’s range113.09 - 116.78
Volume10,071
Average volume (3 months)585,671
Market cap$4.9B
Data as of 3:59pm ET, 08/03/2020

Growth & Valuation

Earnings growth (last year)-117.61%
Earnings growth (this year)+565.75%
Earnings growth (next 5 years)-6.68%
Revenue growth (last year)-11.00%
P/E ratio12.0
Price/Sales2.66
Price/Book1.76

Competitors

 Today’s
change
Today’s
% change
RETAReata Pharmaceutical...+1.49+1.01%
GRFSGrifols SA+0.21+1.11%
MYOKMyoKardia Inc+6.41+7.11%
RAREUltragenyx Pharmaceu...+5.44+6.96%
Data as of 3:59pm ET, 08/03/2020

Financials

Next reporting dateOctober 28, 2020
EPS forecast (this quarter)$2.60
Annual revenue (last year)$1.4B
Annual profit (last year)-$104.5M
Net profit margin-7.21%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Silver Spring, Maryland

Forecasts